Jeffrey J Weiss, PhD Email Jeffrey Weiss
- ASSOCIATE PROFESSOR | Medicine, General Internal Medicine
- ASSISTANT PROFESSOR | Psychiatry
- Hospital Affiliation
- The Mount Sinai Hospital
Dr. Weiss is an Associate Professor in the Department of Medicine, Assistant Professor in the Department of Psychiatry, and Director of the Hepatitis C Clinical & Research Program in the Division of General Internal Medicine.
Dr. Weiss has worked for over 20 years in the United States and Europe as a licensed clinical psychologist providing care to persons with infectious diseases and conducting research on how behavioral interventions can improve their quality and length of life. He has developed the Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C), an open-access web-based provider tool to assess patient readiness to begin treatment for Hepatitis C infection.
AIDS/HIV, Addiction, Behavior, Hepatitis C Virus
Multi-Disciplinary Training Area
Public Health [PH]
AB, Stanford University
MS, Fairleigh Dickinson University
PHD, Northwestern University
Internship, Clinical Psychology
Michael Reese Hospital
NIH GRANT R34 MH099930
August 5, 2013 - July 31, 2016
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
End-stage liver disease, predominantly due to hepatitis C virus (HCV) infection, is one of the leading causes of death in person living with HIV infection. While HCV is curable and recent advances in treatment have increased the rates of cure, few patients with HIV and HCV are being treated to cure HCV. This study will develop and test a behavioral intervention to increase the rates of HCV treatment initiation and adherence in HIV-positive persons with HCV co-infection.
Keywords: HIV, HCV, Adherence
Pizzirusso M, Lin J, Head C, Marcus SM, Ahmed S, Bräu N, Weiss JJ. Impact of hepatitis C treatment initiation on adherence to concomitant medications. The Journal of the Association of Nurses in AIDS Care : JANAC 2014; 25(1).
Mattocks KM, Sadler A, Yano EM, Krebs EE, Zephyrin L, Brandt C, Kimerling R, Sandfort T, Dichter ME, Weiss JJ, Allison J, Haskell S. Sexual victimization, health status, and VA healthcare utilization among lesbian and bisexual OEF/OIF veterans. Journal of general internal medicine 2013 Jul; 28 Suppl 2.
Weiss JJ, Alcorn MC, Rabkin JG, Dieterich DT. The critical role of medication adherence in the success of boceprevir and telaprevir in clinical practice. Journal of hepatology 2012 Feb; 56(2).
Zhang JP, Weiss JJ, McCardle M, Klopchin H, Rosendahl E, Maayan L, Convit A, Kane JM, Manu P, Correll CU. Effectiveness of a cognitive behavioral weight management intervention in obese patients with psychotic disorders compared to patients with nonpsychotic disorders or no psychiatric disorders: results from a 12-month, real-world study. Journal of clinical psychopharmacology 2012 Aug; 32(4).
Weiss JJ, Osorio G, Ryan E, Marcus S, Fishbein D. Prevalence and patient awareness of medical comorbities in an urban AIDS clinic.. AIDS Patient Care & STDs 2010; 24: 39-48.
Weiss JJ, Morgello S. Psychiatric management of HIV/HCV-coinfected patients beginning treatment for hepatitis C virus infection: Survey of provider practices.. General Hospital Psychiatry 2009; 31: 531-537.
Weiss JJ, Brau N, Stivala A, Swan T, Fishbein D. Adherence to medication for chronic hepatitis C: Building on the model of human immunodeficiency virus antiretroviral adherence research.. Alimentary Pharmacology & Therapeutics 2009; 30: 14-27.
Weiss JJ, Bhatti L, Dieterich DT, Edlin BR, Fishbein DA, Goetz MB, Yu K, Wagner GJ. Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin. Alimentary Pharmacology & Therapeutics 2008; 28: 289-293.
Weiss JJ, Bangsberg DR. Comprehensive Textbook of AIDS Psychiatry (2008). In: Cohen MA, Gorman JM, editors. Psychiatric Aspects of Adherence to Medical Care and Treatment in HIV/AIDS
Comprehensive Textbook of AIDS Psychiatry (2008). New York, Oxford University Press; pp281-295.
Hutton HH, Santora PB, Weiss JJ. Addiction Treatment: Science and Policy for the Twenty-first Century (2007). In: Henningfield JE, Santora PB, Bickel WK, editors. Addiction and Multiple Morbidities in HIV-Positive Patients
Addiction Treatment: Science and Policy for the Twenty-first Century (2007). Baltimore, The Johns Hopkins University Press;.
Niego SH, Kofman MD, Weiss JJ, Geliebter A. Binge eating in the bariatric surgery population: A review of the literature. International Journal of Eating Disorders 2007; 40: 349-359.
Weiss JJ, Gorman JM. Psychiatric Behavioral Aspects of Co-management of HCV and HIV. Current HIV/AIDS Reports 2006; 3: 176-181.
Weiss JJ, Gorman JM. Antidepressant adherence and suicide risk in depressed youth [Letter to the editor]. American Journal of Psychiatry 2005; 162: 1756-1757.
Hoffman RG, Cohen MA, Alfonso CA, Weiss JJ, Jones S, Keller M, Condemarin JR, Chiu N, Jacobson JM. Treatment of interferon-induced psychosis in patients with comorbid hepatitis C and HIV. Psychosomatics 2003; 44: 417-420.
Knippels H, Goodkin K, Weiss JJ, Wilkie FL, Antoni MH. The importance of cognitive self-report in early HIV-1 infection: Validation of a cognitive functional status sub-scale. AIDS 2002; 16: 259-267.
Weiss JJ. AIDS in Europe: New Challenges for the Social Sciences (2000). In: Moatti JP, Souteyrand Y, Prieur A, Sandfort T, Aggleton P, editors. Attitudinal factors and adherence to protease inhibitor combination therapy
AIDS in Europe: New Challenges for the Social Sciences (2000). London, Routledge; pp45-56.
Weiss JJ, Mulder CL, Antoni MH, de Vroome EM, Garssen B, Goodkin K. Effects of a supportive-expressive group intervention on long-term psychosocial adjustment in HIV-infected gay men. Psychotherapy and Psychosomatics 2003; 72: 132-140.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Weiss did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.